Latest / The BioHub - by Avetix
Episode 127 - Ann Belien - Founder and CEO Rejuvenate Biomed
Ann is the Founder and CEO of Rejuvenate Biomed, a clinical-stage biotechnology company developing combination therapies aimed at targeting the biological mechanisms behind age-related diseases. With more than two decades of experience in pharmaceutical research and development, she has built a career focused on translating cutting-edge science into therapies that can improve patients’ lives.
Before launching Rejuvenate Biomed in 2017, Ann held leadership roles at Janssen Pharmaceuticals, part of Johnson & Johnson, where she worked across drug discovery, development, and innovation strategy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.